Niagen Bioscience, Inc.
US ˙ NasdaqCM ˙ US1710774076

SecurityNAGE / Niagen Bioscience, Inc.
InstitutionMercer Global Advisors Inc /adv
Latest Disclosed Ownership40,966 shares
Latest Disclosed Value $ 180,660
Mercer Global Advisors Inc /adv reports 66.84% increase in ownership of NAGE / Niagen Bioscience, Inc.

On May 15, 2026 - Mercer Global Advisors Inc /adv filed a 13F-HR form disclosing ownership of 40,966 shares of Niagen Bioscience, Inc. (US:NAGE) valued at $180,660 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 24,554 shares of Niagen Bioscience, Inc.. This represents a change in shares of 66.84% during the quarter. The current value of the position is $141,333 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 40,966 16,412 66.84 181 15.38 0.0003
2026-02-17 2025-12-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 24,554 831 3.50 156 -29.41 0.0002
2025-11-14 2025-09-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 23,723 3,000 14.48 221 -25.84 0.0004
2025-08-14 2025-06-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 20,723 2,583 14.24 299 138.40 0.0006
2025-05-15 2025-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 18,140 8,140 81.40 125 135.85 0.0003
2025-02-14 2024-12-31 13F CHROMADEX COM NEW 171077407 10,000 10,000 53 0.0001
2024-08-12 2024-06-30 13F CHROMADEX COM NEW 171077407 0 -10,000 -100.00 0 0.0000
2024-05-15 2024-03-31 13F CHROMADEX COM NEW 171077407 10,000 10,000 0 0.0001
2024-02-14 2023-12-31 13F CHROMADEX COM NEW 171077407 0 -10,000 -100.00 0 0.0000
2023-11-15 2023-09-30 13F/A-1 CHROMADEX COM NEW 171077407 10,000 10,000 0 0.0001
2023-11-14 2023-09-30 13F CHROMADEX COM NEW 171077407 10,000 10,000 0 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.